Get the Stockscreener App
1.28
4.48%
-0.06
After Hours:
1.24
-0.04
-3.13%
Opko Health Inc stock is traded at $1.28, with a volume of 4.28M.
It is down -4.48% in the last 24 hours and down -3.03% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
See More
Previous Close:
$1.34
Open:
$1.32
24h Volume:
4.28M
Relative Volume:
1.37
Market Cap:
$1.02B
Revenue:
$711.41M
Net Income/Loss:
$-133.73M
P/E Ratio:
-6.7368
EPS:
-0.19
Net Cash Flow:
$-199.99M
1W Performance:
-8.57%
1M Performance:
-3.03%
6M Performance:
-15.79%
1Y Performance:
-9.86%
1-Day Range:
$1.27
$1.34
1-Week Range:
$1.27
$1.3958
52-Week Range:
$1.21
$2.035
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.28 | 1.06B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-25-25 | Initiated | JP Morgan | Neutral |
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
OPKO Health Ups Buyback As Losses Widen And Revenue Falls - Finimize
OPKO Health's Q2 2025: Unpacking Contradictions in NGENLA, Diagnostics Margins, and BARDA Revenue - AInvest
Opko Health earnings missed by $0.08, revenue fell short of estimates - Investing.com Canada
Why is OPKO Health Inc. stock attracting strong analyst attentionAdvanced Screener Ideas For Every Investor - jammulinksnews.com
Earnings call transcript: Opko Health Q2 2025 misses EPS, stock drops - Investing.com
Opko Health shares fall 3.13% after-hours as Q2 revenue drops and losses exceed expectations. - AInvest
Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics - Nasdaq
OPKO Health: Navigating Revenue Downturns and Strategic Rebuilding in a Competitive Medical Instruments Landscape - AInvest
How many analysts rate OPKO Health Inc. as a “Buy”Financial News Data Feed With High Returns - jammulinksnews.com
OPKO Health: Q2 Earnings Snapshot - San Antonio Express-News
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results - Yahoo Finance
10 Penny Stocks That Will Skyrocket - Insider Monkey
RSI + MACD Show Convergence for OPKO Health Inc.AI Screening for Swing Trade Picks Finds Momentum - metal.it
Price Channel Expanding on OPKO Health Inc.’s ChartSwing Trade Entry With Volume Triggers Released - metal.it
GSA Capital Partners LLP Boosts Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Why did OPK's Q4 earnings surprise analysts? - AInvest
Trendline Breach Raises Concern for OPKO Health Inc. InvestorsAlpha Driven Watchlist With Alerts Published - metal.it
How high can OPKO Health Inc. stock price go in 2025Real Trader Watchlist of Hot Stocks Released - metal.it
What institutional investors are buying OPKO Health Inc. stockHigh-profit stock alerts - jammulinksnews.com
Is it the right time to buy OPKO Health Inc. stockGame-changing capital returns - jammulinksnews.com
Is OPKO Health Inc. a growth stock or a value stockConsistently superior profits - jammulinksnews.com
What is the risk reward ratio of investing in OPKO Health Inc. stockExplosive earning power - jammulinksnews.com
OPKO Health Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Wealth-Building Investment Strategies - metal.it
Published on: 2025-07-28 05:14:37 - jammulinksnews.com
What are OPKO Health Inc. company’s key revenue driversInvest smarter with expert stock picks - jammulinksnews.com
How strong is OPKO Health Inc. company’s balance sheetGet exclusive market insights for better trading - jammulinksnews.com
OPKO Health Inc. Company’s Quarterly Earnings Growth: What the Numbers SayParabolic Move Ideas - metal.it
What are the technical indicators suggesting about OPKO Health Inc.Explosive market performance - jammulinksnews.com
Published on: 2025-07-27 22:06:52 - jammulinksnews.com
OPKO Health (OPK) Projected to Post Earnings on Thursday - MarketBeat
What is the dividend policy of OPKO Health Inc. stockDynamic investment opportunities - jammulinksnews.com
Earnings Preview: Opko Health to Report Financial Results Post-market on July 31 - 富途牛牛
Is OPKO Health Inc. a good long term investmentFree Investment Community - PrintWeekIndia
What drives OPKO Health Inc. stock priceExplosive capital appreciation - PrintWeekIndia
Is OPKO Health Inc. stock a good hedge against inflationDynamic capital growth - jammulinksnews.com
OPKO Health to Report Second Quarter 2025 Financial Results on July 31 - GlobeNewswire
Investors in OPKO Health (NASDAQ:OPK) From Five Years Ago Are Still Down 75%, Even After 5.1% Gain This Past Week - 富途牛牛
The recent 5.1% gain must have brightened CEO Phillip Frost's week, OPKO Health, Inc.'s (NASDAQ:OPK) most bullish insider - simplywall.st
What analysts say about OPKO Health Inc. stockTurbocharged investment results - Autocar Professional
OPKO Health’s (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX) - Insider Monkey
OPKO Health Inc. Stock Analysis and ForecastTremendous portfolio expansion - jammulinksnews.com
11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):